Application 219859
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 25MG | No | No |
| 002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 50MG | No | No |
| 003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219859-001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | |
| A219859-003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219859-001 | AB |
| A219859-002 | AB |
| A219859-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2025-09-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219859-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219859-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219859-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A219859-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219859-003 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219859-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium | LOSARTAN POTASSIUM | St. Mary's Medical Park Pharmacy | aaf943ff-d6af-8ce2-e053-2995a90a7b76 | 2026-06-07 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Cardinal Health 107, LLC | b83d896a-c7e9-4508-814c-425b88a87b16 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 0f3a6984-e601-4a74-9910-49ee5e352d6b | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Coupler LLC | 53456224-db79-e7c1-e063-6394a90a90d5 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals Inc. | c4b81f90-bcd0-45d0-99ce-35ca998d473a | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losortan Potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals Inc. | 25651749-8950-43ff-bcbd-3bb85f57a360 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals, Inc. | fe1df76d-4925-444d-8e30-9dd07f205fb7 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | f9a92771-5c73-4f17-ac38-29fabfd4a919 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 5f7612dc-dccf-49e2-b541-3dab9dc1f97a | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | abb56236-f2fe-45b5-93ac-35fd661f8992 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losortan Potassium | LOSARTAN POTASSIUM | Bryant Ranch Prepack | 1b285c10-f468-4d87-b36d-79047f686c58 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 23117ad8-39ad-44f2-b7d2-2dbc8edc9734 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | d7b61f05-871d-4ffd-ab9b-9a3e60fd34c4 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals Inc. | 05818573-0b40-4731-a9d1-152c708905bf | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | Losartan potassium LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 4d60e755-40a6-4187-b09e-e55c735945aa | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | NuCare Pharmaceuticals,Inc. | ba76eb91-bea6-4e37-e053-2a95a90a065a | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 372ba4ad-26ca-4675-8475-4b664fbecba9 | 2026-02-16 | Boxed warning, Warnings, Adverse reactions | LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 3ee3240f-78a1-4fd2-a779-c22693711721 | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | f29cc61a-afba-4ecb-8043-5f103872f1ae | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
| Losartan Potassium | LOSARTAN POTASSIUM | A-S Medication Solutions | 2c810cde-fa40-4772-806e-c31809e6bbfb | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | Losartan Potassium LOSARTAN POTASSIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.